TEFIDSOGENE CIVAPARVOVEC
UNII 2V7PRS3ISP

Substance Identification & Data

This profile provides standardized clinical and technical data for Tefidsogene Civaparvovec, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2V7PRS3ISP.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2143580-10-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
2V7PRS3ISP
CAS Registry Number
2143580-10-1
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
TEFIDSOGENE CIVAPARVOVEC
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
10981
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
structurallyDiverse
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tefidsogene Civaparvovec. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TEFIDSOGENE CIVAPARVOVEC

Common Names & Synonyms

SB-913
TEFIDSOGENE CIVAPARVOVEC [INN]

Systematic Nomenclature

A RECOMBINANT NON-REPLICATING ADENO-ASSOCIATED VIRUS TYPE 2/6 (RAAV REP2-CAP6) VECTOR, WHICH CONTAINS A PROMOTER-LESS HUMAN IDURONATE 2-SULFATASE (HIDS) TRANSGENE CASSETTE, ENCODING PARTS OF EXON 1 PLUS EXONS 2-9 FROM HIDS AND A SPLICE ACCEPTOR SITE (SA) DERIVED FROM HUMAN COAGULATION FACTOR IX (HF9, FACTOR IX OR FIX) EXON 2, FLANKED BY A SEQUENCE HOMOLOGOUS TO THE ZINC-FINGER NUCLEASE (ZFN) CLEAVAGE SITE OF THE HUMAN ALBUMIN (HALB) INTRON 1